Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome

29 May 2012

Abstract excerpt

BACKGROUND: The aim of this study was to compare gene copy number (GCN) and protein expression of MET and to evaluate their prognostic roles in gastric carcinomas. METHODS: MET protein expression and gene amplification (GA) status were determined by immunohistochemistry (IHC) and silver in-situ hybridisation (SISH), respectively, in a large series of gastric carcinoma. RESULTS: Protein overexpression was observed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to Liver physiology and pathology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22644302
DOI: 10.1038/bjc.2012.237

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcomePMID 22644302Read ↗

Impact of MET amplification on gastric cancer: Possible roles as a novel prognostic marker and a potential therapeutic targetSemantic proximity Read ↗

<i>MET</i> amplification as a potential therapeutic target in gastric cancerSemantic proximity Read ↗

MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.Semantic proximity Read ↗

MET-amplified gastric cancers exhibit co-amplifications of BRAF, CDK6, and EGFR.Semantic proximity Read ↗

MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinomaSemantic proximity Read ↗

Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm.Semantic proximity Read ↗

A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcinoma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurementsSemantic proximity Read ↗

Assessment of ERBB2 and EGFR gene amplification and protein expression in gastric carcinoma by immunohistochemistry and fluorescence in situ hybridizationSemantic proximity Read ↗

A study of HER2 gene amplification and protein expression in gastric cancerSemantic proximity Read ↗

MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.Semantic proximity Read ↗

Gastric cancer patient with c-MET amplification treated with crizotinib after failed multi-line treatment: A case report and literature reviewSemantic proximity Read ↗

A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.